FDA greenlights Lilly’s EBGLYSS for ultra-low-frequency dosing in eczema breakthrough

The move makes EBGLYSS the only therapy offering as few as six maintenance injections per year

DFE Pharma earns third consecutive EcoVadis Gold Medal for sustainability excellence

Recognition places pharmaceutical excipients leader among the top 5% of companies globally, highlighting progress in emissions reduction, responsible sourcing, and sustainable supply chain practices

Novo Nordisk’s CagriSema delivers strong Phase 3 results across REIMAGINE diabetes trials

Wegovy pill smashes past 3mn prescriptions in under six months in US

The company said Wegovy hit its first one million prescriptions within 12 weeks of availability

FUJIFILM brings next-gen AI-enabled digital mammography platform to India

First installation of AI-powered AMULET SOPHINITY at NM Medical aims to strengthen early breast cancer detection

Merck signs MoU with CSIR-IICT to strengthen industry-academia ties

The collaboration will foster joint research initiatives, scientific knowledge exchange, and innovation

Lilly’s oral GLP-1 drug Orforglipron outperforms Semaglutide in phase 3 diabetes trial

Based on the cumulative data from ACHIEVE-1 through ACHIEVE-5, Lilly plans to submit orforglipron for FDA approval for the treatment of type 2 diabetes by the end of the second quarter

Bayer brings Alka-Seltzer to India touting first antacid with probiotic support

The launch comes against the backdrop of a significant public health burden

FDA expands Pfizer’s HYMPAVZI approval

Broadening access for children & patients with inhibitor-complicated hemophilia

Mariska Hargitay launches Bristol Myers Squibb's Myeloma Awareness Campaign

The campaign places renewed focus on a disease that remains incurable despite major scientific advances